PI3Kδ/γ-IN-3(Compound 58)是一种口服有效的 PI3Kδ 和 PI3Kγ 双抑制剂,IC50 值分别为 1 nM 和 16 nM,可诱导肿瘤细胞凋亡(apoptosis),并可用于 B 细胞恶性肿瘤的研究。
产品编号: MS-J86077 CAS No.: 2730151-31-0 分子式: C23H20ClN9O 分子量: 473.92
MolStrong 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务
规格 价格 是否有货 数量 购物车
50mg
询价
询价
100mg
询价
询价
250mg
询价
询价

产品描述

PI3Kδ/γ-IN-3(Compound 58)是一种口服有效的 PI3Kδ 和 PI3Kγ 双抑制剂,IC50 值分别为 1 nM 和 16 nM,可诱导肿瘤细胞凋亡(apoptosis),并可用于 B 细胞恶性肿瘤的研究。

生物实验数据

生物活性 PI3Kδ/γ-IN-3 (Compound 58) is an orally active dual inhibitor of PI3Kδ and PI3Kγ with IC50 values of 1 nM and 16 nM, respectively, which induces tumor cell apoptosis and can be used for research on B-cell malignancies.
IC50 & Target PI3Kγ:16 nM, PI3Kδ:1 nM
体外研究
(In Vitro)

PI3Kδ/γ-IN-3 (Compound 58) (72 h) shows antiproliferative activity against B-cell lymphoma (DLBCL) cells.
PI3Kδ/γ-IN-3 (0.5 μM, 24 h) arrests cell cycle at G0/G1 phase in SUDHL-6 and DOHH2 cells.
PI3Kδ/γ-IN-3 (1.5 and 2 μM, 48 h) induces cell apoptosis in SUDHL-6 and DOHH2 cells.

Cell Proliferation Assay

Cell Line: SUDHL-4, SUDHL-6 and DOHH2 cells
Concentration:
Incubation Time: 72 h
Result: Showed antiproliferative activity with IC50s of 0.03 ± 0.03, 0.06 ± 0.01 and 0.20 ± 0.04 μM against SUDHL-4, SUDHL-6 and DOHH2 cells, respectively.

Cell Cycle Analysis

Cell Line: SUDHL-6 and DOHH2 cells
Concentration: 0.5 μM
Incubation Time: Alone or in combination with Ibrutininb (MS-M40234) (0.5 μM or 1 μM) for 24 h
Result: Caused a loss of G2/M phase cells and an increase in the percentage of cells in the G0/G1 phase. Induced cell cycle arrest alone or in combination with Ibrutinib in both cells.

Apoptosis Analysis

Cell Line: SUDHL-6 and DOHH2 cells
Concentration: 1.5 μM and 2 μM
Incubation Time: Alone or in combination with Ibrutininb (1.5 μM or 1 μM) for 48 h
Result: Demonstrated the induction of apoptosis in both SUDHL-6 and DOHH2 cells, and the combination was stronger than treated alone.
体内研究
(In Vivo)

PI3Kδ/γ-IN-3 (Compound 58) (5 and 10 mg/kg; p.o.; daily for 14d) suppresses the tumor volume in a dose-dependent manner without obvious toxicity in mice.

Animal Model: Female non obese diabetes/severe combined immunodeficient (NOD/SCID) mice, 6- to 8-week-old, SUDHL-6 xenograft model
Dosage: 5 and 10 mg/kg alone or in combination with 10 mg/kg Ibrutinib
Administration: Oral administration, daily for 14 days
Result: Suppressed the tumor volume in a dose-dependent manner and demonstrated superior efficacy relative to Ibrutinib at 10 mg/kg QD administration. When in combination with Ibrutinib, showed greater tumor growth inhibitory effects.
Animal Model: SD rats
Dosage: 5 mg/kg
Administration: Oral or intravenous administration (Pharmacokinetic Analysis)
Result: PK Profiles of PI3Kδ/γ-IN-3 (Compound 58) in Male SD Rats
Compound dose (mg/kg) administration route Cmax (ng/mL) Tmax (h) AUC0-t (h•μg/L) T1/2 (h) CL (L/h/kg) Vss(L/kg) F (%)
58 5 oral 3637.81 3.33 8612.57 9.46 0.79 -- 126.5
5 intravenous 860.09 0.08 6806.92 2.79 0.75 2.86 --

PK profiles: Cmax, maximum plasma concentration; Tmax, tim

化学信息

分子量 473.92
分子式 C23H20ClN9O
CAS No. 2730151-31-0

储存&溶解度

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

运输条件 Room temperature in continental US; may vary elsewhere.

计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
起始浓度(M)× 起始体积(L)= 最终浓度(M)× 最终体积(L)
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2
溶液体积 = 质量 ÷ 配液浓度
Volume (to add to vial) = Mass (in vial) ÷ Desired Reconstitution Concentration
÷
分子量计算器
Enter the chemical formula of the compound to calculate its molar mass and elemental composition
g/mol

体内实验配液计算器

动物实验计算换算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:

比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL, 一共给药动物10只,您使用的配方为 10% DMSO + 40% PEG300 + 5% Tween 80 + 45% Saline / PBS / ddH2O, 那么您的工作液浓度为2 mg/mL。

母液配置方法:2 mg 药物溶于 100 μL DMSO ( 母液浓度为 20 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。

体内配方的制备方法: 取 100 μL DMSO 母液, 添加 400 μL PEG300 混匀澄清, 再加 50 μL Tween 80, 混匀澄清, 再加 450 μL Saline / PBS / ddH2O 混匀澄清

以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。

方案所需的各类助溶剂如: DMSO, PEG300, PEG400, Tween 80, SBE-β-CD, 玉米油等, 均可在MolStrong网站点击购买。

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系客服为您提供正确的澄清溶液配方)
+
+
+

计算结果:

工作液浓度: mg/ml;

DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,

体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL Saline/PBS/ddH2O,混匀澄清。

1. 首先保证母液是澄清的;
           2. 一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础